# Development of Motavizumab, an Ultra-potent Antibody for the Prevention of Respiratory Syncytial Virus Infection in the Upper and Lower Respiratory Tract

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/development-of-motavizumab-an-ultra-potent-antibody-for-the-prevention-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Herren Wu,David S. Pfarr,Syd Johnson,Yambasu A. Brewah,Robert M. Woods,Nita Patel,Wendy I. White,James F. Young,Peter A. Kiener |
| Citations | 382 |
| DOI | 10.1016/j.jmb.2007.02.024 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2093529351 |
| PMID | 17362988 |
| Type | article |
| Year | 2007 |

## Paper authors

- [Nita Patel](https://scholariq.org/researchers/nita-patel/)

## Paper primary topic

- [Respiratory viral infections research](https://scholariq.org/topics/respiratory-viral-infections-research/)

## Paper topics

- [Respiratory viral infections research](https://scholariq.org/topics/respiratory-viral-infections-research/)
- [Viral gastroenteritis research and epidemiology](https://scholariq.org/topics/viral-gastroenteritis-research-and-epidemiology/)
- [Virus-based gene therapy research](https://scholariq.org/topics/virus-based-gene-therapy-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.